SPACE - Study of Prophylaxis, Activity and Effectiveness in Hemophilia Patients Currently Treated with Advate or Rixubis

Grants and Contracts Details

StatusFinished
Effective start/end date11/19/14 → 10/30/16

Funding

  • Baxter Healthcare Co: $17,220.00